NEW YORK (GenomeWeb) – Trovagene announced today that it has completed a reorganization effort that it believes will allow it to refocus its efforts on the global distribution of liquid biopsy kits and systems to clinical research laboratories.

The company — which also cut 20 jobs — estimated that the staff reductions, combined with a lowering of expenses associated with marketing CLIA lab testing directly to medical professionals, will reduce its annual pre-tax expenses by approximately $4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.